Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1982 1
1983 2
1984 2
1985 1
1986 5
1987 1
1988 1
1989 5
1990 5
1991 5
1992 1
1993 8
1994 8
1995 10
1996 8
1997 5
1998 12
1999 9
2000 18
2001 10
2002 18
2003 19
2004 17
2005 29
2006 30
2007 28
2008 36
2009 33
2010 42
2011 33
2012 29
2013 37
2014 47
2015 46
2016 43
2017 59
2018 54
2019 74
2020 70
2021 101
2022 94
2023 101
2024 29

Text availability

Article attribute

Article type

Publication date

Search Results

1,074 results

Results by year

Filters applied: . Clear all
Page 1
Saccharomyces boulardii: What Makes It Tick as Successful Probiotic?
Pais P, Almeida V, Yılmaz M, Teixeira MC. Pais P, et al. J Fungi (Basel). 2020 Jun 4;6(2):78. doi: 10.3390/jof6020078. J Fungi (Basel). 2020. PMID: 32512834 Free PMC article. Review.
Saccharomyces boulardii is a probiotic yeast often used for the treatment of GI tract disorders such as diarrhea symptoms. It is genetically close to the model yeast Saccharomyces cerevisiae and its classification as a distinct species or a S. cerevisiae vari
Saccharomyces boulardii is a probiotic yeast often used for the treatment of GI tract disorders such as diarrhea symptoms. It
Systematic review and meta-analysis of Saccharomyces boulardii in adult patients.
McFarland LV. McFarland LV. World J Gastroenterol. 2010 May 14;16(18):2202-22. doi: 10.3748/wjg.v16.i18.2202. World J Gastroenterol. 2010. PMID: 20458757 Free PMC article. Review.
This article reviews the evidence for efficacy and safety of Saccharomyces boulardii (S. boulardii) for various disease indications in adults based on the peer-reviewed, randomized clinical trials and pre-clinical studies from the published medical literature …
This article reviews the evidence for efficacy and safety of Saccharomyces boulardii (S. boulardii) for various disease …
Saccharomyces boulardii CNCM I-745: A Non-bacterial Microorganism Used as Probiotic Agent in Supporting Treatment of Selected Diseases.
Kaźmierczak-Siedlecka K, Ruszkowski J, Fic M, Folwarski M, Makarewicz W. Kaźmierczak-Siedlecka K, et al. Curr Microbiol. 2020 Sep;77(9):1987-1996. doi: 10.1007/s00284-020-02053-9. Epub 2020 May 29. Curr Microbiol. 2020. PMID: 32472262 Free PMC article. Review.
The yeast Saccharomyces boulardii CNCM I-745 is a unique, non-bacterial microorganism classified as a probiotic agent. ...Even though cases of fungemia following S. boulardii CNCM I-745 administration were reported, it should be treated as a widely available …
The yeast Saccharomyces boulardii CNCM I-745 is a unique, non-bacterial microorganism classified as a probiotic agent. ...Even …
Saccharomyces boulardii, a yeast probiotic, inhibits gut motility through upregulating intestinal serotonin transporter and modulating gut microbiota.
Gu Y, Wang C, Qin X, Zhou B, Liu X, Liu T, Xie R, Liu J, Wang B, Cao H. Gu Y, et al. Pharmacol Res. 2022 Jul;181:106291. doi: 10.1016/j.phrs.2022.106291. Epub 2022 Jun 8. Pharmacol Res. 2022. PMID: 35690329
Saccharomyces boulardii (Sb) is a widely used fungal probiotic in treating various digestive diseases, including irritable bowel syndrome (IBS). ...
Saccharomyces boulardii (Sb) is a widely used fungal probiotic in treating various digestive diseases, including irritable bow
Impact of Saccharomyces boulardii CNCM I-745 on Bacterial Overgrowth and Composition of Intestinal Microbiota in Diarrhea-Predominant Irritable Bowel Syndrome Patients: Results of a Randomized Pilot Study.
Bustos Fernández LM, Man F, Lasa JS. Bustos Fernández LM, et al. Dig Dis. 2023;41(5):798-809. doi: 10.1159/000528954. Epub 2023 Jan 11. Dig Dis. 2023. PMID: 36630947 Clinical Trial.
BACKGROUND: Small intestinal bacterial overgrowth (SIBO) is associated with diarrhea-predominant irritable bowel syndrome (IBS-D). Probiotics like Saccharomyces boulardii CNCM I-745 (Sb) may be efficacious in balancing the microbiota. ...Interestingly, F. prausnitzi …
BACKGROUND: Small intestinal bacterial overgrowth (SIBO) is associated with diarrhea-predominant irritable bowel syndrome (IBS-D). Probiotic …
Unique Properties of Yeast Probiotic Saccharomyces boulardii CNCM I-745: A Narrative Review.
Gopalan S, Ganapathy S, Mitra M, Neha, Kumar Joshi D, Veligandla KC, Rathod R, Kotak BP. Gopalan S, et al. Cureus. 2023 Oct 1;15(10):e46314. doi: 10.7759/cureus.46314. eCollection 2023 Oct. Cureus. 2023. PMID: 37927652 Free PMC article. Review.
Probiotics, both bacterial and yeast, have long been associated with a beneficial health history and human well-being. Among yeasts, Saccharomyces is a genus that is efficacious in rendering better human health, with Saccharomyces boulardii (S. boulardii
Probiotics, both bacterial and yeast, have long been associated with a beneficial health history and human well-being. Among yeasts, Sacc
Saccharomyces boulardii CNCM I-745 Improves Intestinal Enzyme Function: A Trophic Effects Review.
Moré MI, Vandenplas Y. Moré MI, et al. Clin Med Insights Gastroenterol. 2018 Feb 9;11:1179552217752679. doi: 10.1177/1179552217752679. eCollection 2018. Clin Med Insights Gastroenterol. 2018. PMID: 29449779 Free PMC article. Review.
Several properties of the probiotic medicinal yeast Saccharomyces boulardii CNCM I-745 contribute to its efficacy to prevent or treat diarrhoea. ...The administration of polyamines or S. boulardii CNCM I-745 enhances the expression of intestinal digestive enz …
Several properties of the probiotic medicinal yeast Saccharomyces boulardii CNCM I-745 contribute to its efficacy to prevent o …
Randomized, direct comparison study of Saccharomyces boulardii CNCM I-745 versus multi-strained Bacillus clausii probiotics for the treatment of pediatric acute gastroenteritis.
Altcheh J, Carosella MV, Ceballos A, D'Andrea U, Jofre SM, Marotta C, Mugeri D, Sabbaj L, Soto A, Josse C, Montestruc F, McFarland LV. Altcheh J, et al. Medicine (Baltimore). 2022 Sep 9;101(36):e30500. doi: 10.1097/MD.0000000000030500. Medicine (Baltimore). 2022. PMID: 36086703 Free PMC article. Clinical Trial.
Our aim was to compare the efficacy and safety of 2 probiotics (Saccharomyces boulardii CNCM I-745 vs a 4-strain mixture of Bacillus clausii O/C, SIN, N/R, T) for the treatment of PAGE. ...A total of 317 children were enrolled and blindly randomized to 5 days of eit …
Our aim was to compare the efficacy and safety of 2 probiotics (Saccharomyces boulardii CNCM I-745 vs a 4-strain mixture of Ba …
Review of Saccharomyces boulardii as a treatment option in IBD.
Sivananthan K, Petersen AM. Sivananthan K, et al. Immunopharmacol Immunotoxicol. 2018 Dec;40(6):465-475. doi: 10.1080/08923973.2018.1469143. Epub 2018 May 17. Immunopharmacol Immunotoxicol. 2018. PMID: 29771163 Review.
CONTEXT: Review of the yeast Saccharomyces boulardii as a treatment option for the inflammatory bowel diseases (IBD) ulcerative colitis and Crohn's disease. ...In this review, we have looked at the evidence for the yeast S. boulardii as a treatment option. MA …
CONTEXT: Review of the yeast Saccharomyces boulardii as a treatment option for the inflammatory bowel diseases (IBD) ulcerativ …
Saccharomyces boulardii in childhood.
Vandenplas Y, Brunser O, Szajewska H. Vandenplas Y, et al. Eur J Pediatr. 2009 Mar;168(3):253-65. doi: 10.1007/s00431-008-0879-7. Epub 2008 Dec 19. Eur J Pediatr. 2009. PMID: 19096876 Review.
INTRODUCTION: Probiotics are live microorganisms which confer a health benefit on the host. Saccharomyces boulardii, a yeast, has been found to be an effective probiotic in double-blind placebo-controlled randomized clinical studies. MATERIALS AND METHODS: We review …
INTRODUCTION: Probiotics are live microorganisms which confer a health benefit on the host. Saccharomyces boulardii, a yeast, …
1,074 results